These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 303173)

  • 41. [Antitumor effects of liposome-entrapped carboplatin (Lipo-CBDCA) after intraperitoneal administration in rats bearing carcinomatous peritonitis].
    Mizuno I; Yasui T; Takeyama H; Ishikawa M; Terada J; Mohri N; Ueda T; Sumita N; Kobayashi K; Akamo Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1598-601. PubMed ID: 7574769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effects of intraperitoneal vitamin C, aprotinin and melatonin administration on retinal edema during experimental uveitis in the guinea pig.
    Kükner AS; Kükner A; Naziroğlu M; Colakoğlu N; Celebi S; Yilmaz T; Aydemir O
    Cell Biochem Funct; 2004; 22(5):299-305. PubMed ID: 15338469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of a proteolysis inhibitor on fibrinolytic activity in acute peritonitis].
    Rubino M; Conte M; Brienza A; Selvaggi F
    Rass Int Clin Ter; 1968 May; 48(10):587-96. PubMed ID: 5307370
    [No Abstract]   [Full Text] [Related]  

  • 44. Auto-cross-linked hyaluronic acid gel does not reduce intra-abdominal adhesions or abscess formation in a rat model of peritonitis.
    Sikkink CJ; de Man B; Bleichrodt RP; van Goor H
    J Surg Res; 2006 Dec; 136(2):255-9. PubMed ID: 17059836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Trasylol effects. 3. Trasylol effect on the degranulation of circulating blood platelets and mobilization of neutrophilic granulocytes during experimental peritonitis].
    Kifor E; Werle E
    Blut; 1973 Mar; 26(3):188-92. PubMed ID: 4540325
    [No Abstract]   [Full Text] [Related]  

  • 46. Changes of hepatic sinusoids in experimental septicemia of rats are correlated with the production of nitrogen monoxide. A morphometrical and immunohistochemical study.
    Endo K; Suzuki M; Takahashi T; Unno M; Iwasashi H; Sasaki T; Matsuno S
    Hepatogastroenterology; 2002; 49(43):136-43. PubMed ID: 11941938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of proteolysis inhibitors in pediatric surgical practice].
    Sitkovskiĭ NB; Karavanov AG; Kutsenko TA; Khanes GS
    Khirurgiia (Mosk); 1972 Jun; 48(6):44-8. PubMed ID: 4537820
    [No Abstract]   [Full Text] [Related]  

  • 48. [Peritonitis models in the rat with special reference to laparoscopic therapy options].
    Pross M; Schulz HU; Manger T; Kunz D; Mantke R; Halangk W; Lippert H
    Zentralbl Chir; 1999; 124(8):743-8. PubMed ID: 10488547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
    Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
    Bazargani F
    Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Searle M; Raman GV
    Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anomalous results of high dose chemotherapy in experimental peritonitis.
    Smith IM; Hazard EC
    Surg Gynecol Obstet; 1970 Jan; 130(1):94-8. PubMed ID: 5410639
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pathogenetic mechanisms of peritonitis in acute small intestinal obstruction].
    Miliukov VE; Sapin MR
    Khirurgiia (Mosk); 2005; (7):40-5. PubMed ID: 16091694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A rationale for intraperitoneally administered antibiotic therapy.
    Smith EB
    Surg Gynecol Obstet; 1976 Oct; 143(4):561-4. PubMed ID: 785645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Activating blood circulation and relieving stasis in the treatment of experimental peritonitis].
    Zhou ZL; Wu XZ
    Zhong Xi Yi Jie He Za Zhi; 1988 Jan; 8(1):34-5, 6. PubMed ID: 3383312
    [No Abstract]   [Full Text] [Related]  

  • 56. Intraperitoneal hydrocortisone in eosinophilic peritonitis.
    Katirtzoglou A; Kontesis P; Moschos B; Digenis GE; Symvoulidis A
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1578. PubMed ID: 6405898
    [No Abstract]   [Full Text] [Related]  

  • 57. [An experimental animal study of the use of Contrykal in peritonitis].
    Albert H; Neumann S; Kothe W; Hartig W; Brand G; Engel C
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(1):23-6. PubMed ID: 303173
    [No Abstract]   [Full Text] [Related]  

  • 58. [State of the kallikrein-kinin system and anti-enzyme therapy in acute peritonitis in children].
    Matskevich BI
    Vestn Khir Im I I Grek; 1982 Aug; 129(8):90-4. PubMed ID: 6182678
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of intraperitoneal aprotinin treatment in acute and chronic peritonitis.
    Eckert P; Pfeiffer M; Eichfuss HP
    Adv Exp Med Biol; 1979; 120B():361-6. PubMed ID: 316271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Trasylol and peritonitis].
    Nagel M
    Langenbecks Arch Chir; 1969; 325():327-33. PubMed ID: 5309032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.